S4. Hormone and Metabolic Modulators

If a Substance or Method is not defined in this list, please verify with your Anti-Doping Organization.

The following hormone and metabolic modulators are prohibited:

1. Aromatase inhibitors including, but not limited to:

  • 4-androstene-3,6,17 trione (6-oxo)
  • aminoglutethimide
  • anastrozole
  • androsta-1,4,6-triene-3,17-dione (androstatrienedione)
  • exemestane
  • formestane
  • letrozole
  • testolactone.

2. Selective estrogen receptor modulators (SERMs) including, but not limited to:

  • raloxifene
  • tamoxifen
  • toremifene.

3. Other anti-estrogenic substances including, but not limited to:

  • clomiphene
  • cyclofenil
  • fulvestrant.

4. Agents modifying myostatin function(s) including, but not limited, to:

  • myostatin inhibitors.

5. Metabolic modulators:

  • Activators of the AMP-activated protein kinase (AMPK), e.g. AICAR; and Peroxisome Proliferator Activated Receptor δ (PPARδ) agonists e.g. GW 1516
  • Insulins and insulin-mimetics
  • Meldonium
  • Trimetazidine

If a Substance or Method is not found, please verify with your Anti-Doping Organization to ensure that this Substance or Method is not prohibited as a related Substance or Method that falls under an existing category.